Diligence memo · auto-generated · as of July 3, 2026
BioLogiQ, Inc.
BioLogiQ, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
BioLogiQ, Inc. operates in Manufacturing, based in IDAHO FALLS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BioLogiQ, Inc. has raised $16M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.8M on 2013-01-14.
Most recent recorded round closed around 2018-05-24.
Valuation (modeled)modeled
Provath models BioLogiQ, Inc. at approximately $1.1M (range $160K–$6.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.02× the median modeled value of Series A Manufacturing companies in 2016–2018 (92 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 8.1 yr ago; this sector typically re-raises about every 12 months.
Silent for over 3× the sector's normal cadence.
The last round was 20.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 84% of Manufacturing peers (3257 compared).
Modeled value ranks above 6% of those peers.
Closest niche peers: World Food Holdings, LLC, GLM Energy Services, LLC, Danaher Corp /De/, GFBC, Inc., Health-Ade Llc.
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.